Metastatic apocrine carcinoma of the scalp: prolonged response to systemic chemotherapy.
Tlemcani
Kaoutar
K
Division of Oncology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY, USA.
Levine
Douglas
D
Smith
Richard V
RV
Brandwein-Gensler
Margaret
M
Staffenberg
David A
DA
Garg
Madhur K
MK
Shifteh
Keivan
K
Haigentz
Missak
M
D000505:Alopecia / Q000150:complications; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D001932:Brain Neoplasms / Q000188:drug therapy / Q000556:secondary; D016190:Carboplatin / Q000008:administration & dosage; D002277:Carcinoma / Q000188:drug therapy* / Q000556:secondary*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000556:secondary; D004334:Drug Administration Schedule; D017809:Fatal Outcome; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008207:Lymphatic Metastasis; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage; D012535:Scalp / Q000473:pathology*; D013544:Sweat Gland Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D055815:Young Adult
D016190:Carboplatin; D017239:Paclitaxel